Immune dysregulation workshop Barcelona
From basics to clinics to advanced therapies
FOCIS Center of Excellence CIS-UB: Leading Innovation in Immunology
The CIS-UB (Clínic for Immunology along Sant Joan de Déu in University of Barcelona) is a joint initiative bringing together Hospital Sant Joan de Déu Barcelona, Spain’s leading pediatric hospital; Hospital Clínic de Barcelona, a national reference center for adult care; and the University of Barcelona, a top institution in biomedical teaching and research.
This strategic collaboration integrates patient care, research, and education to advance the diagnosis and treatment of immunological diseases in both children and adults. Through shared units and laboratories, the development of advanced therapies, and participation in international networks, CIS-UB strengthens Barcelona’s position as a hub for immunotherapy, transplantation, autoimmune disorders, and immunodeficiencies, while also training the next generation of specialists and researchers.
A strategic alliance
Shaping the future of Immune Dysregulation
The 4th Immune Dysregulation Workshop will bring together leading international experts for a unique meeting at the forefront of immune dysregulation research, diagnosis, and treatment.
This one-day scientific programme will explore the latest breakthroughs shaping the field, from novel approaches to advanced therapeutics—including allogeneic hematopoietic stem cell transplantation, CAR T-cell therapies for autoimmune diseases, and gene therapy and gene editing—to cutting-edge advances in diagnosis and precision medicine.
Participants will gain insights into emerging challenges and opportunities in immune dysregulation, with sessions exploring gene mosaicism, single-cell analysis, cytokine profiling, and the evolving landscape of immune-targeted therapies. The programme will culminate in inspiring keynote lectures highlighting the frontiers of research and the future of the field.
Join us for an inspiring day where science, innovation, and clinical expertise come together to push the boundaries of immune dysregulation and shape the future of patient care.
At the end of this training you will be able to:
- Explore the latest advances in the understanding, diagnosis, and treatment of immune dysregulation disorders.
- Discover innovative therapeutic strategies, including CAR T-cell therapies, gene therapy, gene editing, and hematopoietic stem cell transplantation.
- Explore emerging diagnostic approaches, from gene mosaicism and single-cell analysis to cytokine profiling.
- Foster international collaboration and exchange knowledge on the future of immune dysregulation research and patient care.
Improve your skills in:
Contents:
Friday 18th December
Location: Barcelona – venue to be confirmed
Table 1:
Advances in therapeutics for immune dysregulation.
Ana Pilar Garcia. Pediatric Clinical Immunology and Immunodeficiencies. Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu Barcelona.
Laia Alsina. Head Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu Barcelona.
Lorena Pérez-Amil. Postdoctoral researcher CaixaResearch Institute Barcelona.
Jordi Antón. Head Pediatric Rheumatology Department, Hospital Sant Joan de Déu Barcelona.
Paula Río. Head of the Bone Marrow Aplasia Unit (Biomedical Innovation Unit, CIEMAT/CIBERER/IIS-FJD, UAM; Madrid, Spain).
Letizia Fontana. Postdoctoral researcher. Grupo de investigación en Institut Imagine de Paris.
Table 2:
Advances in diagnosis in immune dysregulation
Juan I. Aróstegui. Head of Clinical Immunology Section. Immunology department. Hospital Clínic, Barcelona.
Roser Vilarrassa-Blasi. Postdoctoral researcher. Wellcome Sanger Institute. Hinxton, Cambridgeshire, UK.
Angela Deyá. Pediatric Clinical Immunology and Immunodeficiencies. Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu Barcelona.
Cèlia Martí. Pediatric Clinical Immunology and Immunodeficiencies. Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu Barcelona.
Fabrizio de Benedetti. Head of Department Pediatric Rheumatology. Ospedale Bambino Gesú, de Roma.
Table 3:
Keynote sessions: frontiers in immune dysregulation.
Carola García Vinuesa. Principal investigator. Francis Crick Institute, London.
Virginia Pascual. Gale and Ira Drukier Director of Children's Health Research, Weill Cornell Medical College. New York.
Aimed at:
- Physicians (immunologists, pediatricians, hematologists, rheumatologists).
- Clinical researchers and translational scientists.
- Laboratory specialists in immunology and advanced therapies.
- Residents, fellows, and PhD students in related fields.
- Professionals involved in cell and gene therapy development.
Learning experience
We have designed a complete program, carefully prepared with the participation of expert speakers to guarantee you a high-level training experience.
The event is available both in person and online, giving you the flexibility to choose how to participate.
If you choose the online edition, you will need to connect live.
The webinar link will be sent 24 hours before the start of the course.
Learn with international leaders in the specialty, who will share their knowledge and experience in each session.
The program provides spaces for sharing experiences and networking among the participants.
To obtain the certificate, you will be asked to complete a satisfaction survey in the virtual classroom.
Training options
Directed by
Accredited course
European EAACME (SEAFORMEC) accreditation has been requested.
Do you need more information?
Write to us and we’ll answer any questions you may have about the program.